-
1
المؤلفون: Akihide Konishi, Marie Claude Morice, Darren Mylotte, Sunil V. Rao, Olivier Varenne, Stuart J. Pocock, Davide Capodanno, Ernest Spitzer, Dominick J. Angiolillo, Marco Valgimigli, Takeshi Kimura, Thomas Cuisset, Hyo-Soo Kim, Andrew Farb, Deepak L. Bhatt, Norman Stockbridge, John W. Eikelboom, Roxana Mehran, Martin B. Leon, Yoshiaki Mitsutake, C. Michael Gibson, Mitchel W. Krucoff, Philip Urban, Ute Windhovel, Donald E. Cutlip, Roisin Colleran, P. F.Adrian Magee, Michael Haude, Stefan James, John Gregson, Robert A. Byrne, Pedro Eerdmans
المساهمون: University of Catania [Italy], Hôpital Privé Jacques Cartier [Massy], The University of Florida College of Medicine, Harvard Medical School [Boston] (HMS), Technische Universität Munchen - Université Technique de Munich [Munich, Allemagne] (TUM), Département de Cardiologie [Hôpital de la Timone - APHM], Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), DEKRA CONSULTING GMBH STUTTGART DEU, Partenaires IRSTEA, Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA)-Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA), McMaster University [Hamilton, Ontario], Technical University of Munich (TUM)
المصدر: Journal of the American College of Cardiology
Journal of the American College of Cardiology, Elsevier, 2020, 76 (12), pp.1468-1483. ⟨10.1016/j.jacc.2020.06.085⟩
Journal of the American College of Cardiology, 2020, 76 (12), pp.1468-1483. ⟨10.1016/j.jacc.2020.06.085⟩مصطلحات موضوعية: Medtronic, and The Medicines Company, medicine.medical_treatment, Eisai, Design elements and principles, Novartis, 030204 cardiovascular system & hematology, 0302 clinical medicine, Pfizer, Chiesi, 030212 general & internal medicine, CeloNova, Amarin, Boehringer Ingelheim, Gilead, Lexicon, Bristol-Myers Squibb, Ischemix, Synaptic, Osprey Medical, AstraZeneca, Idorsia, Amgen, 3. Good health, Ethicon, Cardiology and Cardiovascular Medicine, Janssen, Bayer, medicine.medical_specialty, Ironwood, Fractyl, Forest Laboratories, Cardax, Target population, 03 medical and health sciences, Ferring Pharmaceuticals, CSL Behring, PhaseBio, medicine, high bleeding risk, Cereno Scientific, Intensive care medicine, Roche, Merck, and the Scott R. MacKenzie Foundation. Dr. Bhatt is an Advisory Board member for Cardax, business.industry, percutaneous coronary intervention, has received royalties from Elsevier, Percutaneous coronary intervention, Afimmune, Regeneron, Daiichi-Sankyo, Clinical trial, Patient population, Biosensors, Matsutani Chemical Industry, PLx Pharma, Conventional PCI, trial design, Renal Guard Solutions, Elsevier Practice Update Cardiology, Eli Lilly, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, Sanofi
-
2
المؤلفون: Janusz Lipiecki, Pedro Eerdmans, Philip Urban, Philippe Brunel, Robaayah Zambahari, Hans-Peter Stoll, Christan Roguelov, Simon J Walsh, Jacques Berland, Marie-Claude Morice, Gert Richardt, Samuel Copt
المصدر: EuroIntervention. 14:e418-e425
مصطلحات موضوعية: Male, Bare-metal stent, medicine.medical_specialty, Polymers, medicine.medical_treatment, 030204 cardiovascular system & hematology, law.invention, 03 medical and health sciences, Percutaneous Coronary Intervention, 0302 clinical medicine, Randomized controlled trial, law, medicine, Humans, cardiovascular diseases, 030212 general & internal medicine, Sirolimus, business.industry, Stent, Percutaneous coronary intervention, Drug-Eluting Stents, Surgery, Clinical trial, Treatment Outcome, Conventional PCI, Platelet aggregation inhibitor, Cardiology and Cardiovascular Medicine, business, Platelet Aggregation Inhibitors, medicine.drug
-
3Academic Journal
المؤلفون: Pedro Eerdmans, Gerrit-anne Van Es, Bernhard Meier, Peter Jüni
المساهمون: The Pennsylvania State University CiteSeerX Archives
وصف الملف: application/pdf
Relation: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.508.869; http://www.kardiologie.usz.ch/SiteCollectionDocuments/LehreUndForschung/publikationen/OR/OR77_windecker_biolimus-eluting_stent_with_biodegradable_polymer.pdf
-
4
المؤلفون: Marco Valgimigli, Takeshi Kimura, Robert W. Yeh, Martin B. Leon, Dominick J. Angiolillo, Roxana Mehran, Mitchell W. Krucoff, Stuart J. Pocock, Yoshiaki Mitsutake, Ernest Spitzer, P. F.Adrian Magee, Andrew Farb, Akihide Konishi, Matthew J. Price, Davide Capodanno, Olivier Varenne, Ute Windhoevel, Roisin Colleran, Philip Urban, C. Michael Gibson, Darren Mylotte, Donald E. Cutlip, Thomas Cuisset, Hyo-Soo Kim, John C. Laschinger, Stefan James, Michael Haude, John Gregson, Marie Claude Morice, John Eikelboom, Norman Stockbridge, Sunil V. Rao, Pedro Eerdmans, Robert A. Byrne
المساهمون: Hôpital de la Tour, Cardiovascular Research Foundation, Technische Universität Munchen - Université Technique de Munich [Munich, Allemagne] (TUM), University of Florida [Gainesville] (UF), University of Catania [Italy], Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Hôpital de la Timone [CHU - APHM] (TIMONE), Harvard Medical School [Boston] (HMS), AUTRES, McMaster University [Hamilton, Ontario], U.S. Food and Drug Administration (FDA), London School of Hygiene and Tropical Medicine (LSHTM), Lukaskrankenhaus, Uppsala University, Seoul National University Hospital, Kyoto University, Pharmaceuticals and Medical Devices Agency, Columbia University [New York], National University of Ireland [Galway] (NUI Galway), Scripps Clinic [San Diego, CA, USA], Duke Clinical Research Institute, Duke University Medical Center, Erasmus University Medical Center [Rotterdam] (Erasmus MC), University of Bern, Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Cardiovascular European Research Center, Beth Israel Deaconess Medical Center [Boston] (BIDMC), Hôpital Privé Jacques Cartier [Massy], The ARC-HBR group was entirely funded by multiple industry sponsors. Sponsors participated as observers in both meetings and were provided a copy of the document before submission. The contributing companies were Abbott Vascular, Alvimedica, Amgen, AstraZeneca, Biosensors, Biotronik, Boston Scientific, Celonova, Chiesi, Cordis, Daiichi Sankyo, Edwards Lifesciences, Janssen, Medinol, Medtronic, Orbusneich, Portola, Sanofi, Sinomed, Sahajanand Medical Technologies, and Terumo.Conflict of interest: Dr Colleran received financial compensation for her contribution to the preparation of this document. In accordance with the ARC charter, none of the other participants received fees or honoraria for their participation in the meetings or their contribution to this document. Dr Urban reports receiving speaker and consulting honoraria as an individual from Biosensors-Europe, Sinomed, and Terumo, participating in paid review activities (Clinical End Point Committee, Data Safety Monitoring Board) for Edward Lifesciences, Terumo, and Abbott Vascular, and serving as a medical codirector at the Cardiovascular European Research Center, a contract research organization based in Massy, France. Dr Mehran reports consultant fees to the institution from Abbott Laboratories and Spectranetics/Philips/Valcano Corp, consulting fees from Boston Scientific, Cardiovascular Systems Inc, Medscape, Siemens Medical Solutions, Regeneron Pharmaceuticals Inc, Roivant Sciences Inc, and Sanofi, being the spouse of a consultant for Abiomed and The Medicines Company, research funding to the institution from AstraZeneca, Bayer, Beth Israel Deaconess Hospital, BMS, CSL Behring, Eli Lilly and DSI, Medtronic, Novartis Pharmaceuticals, and Orbus Neich, scientific advisory board fees from PLx Opco Inc, dba PLx Pharma Inc, scientific advisory board fees to the institution from Bristol-Myers Squibb, executive committee fees from Janssen Pharmaceuticals and Osprey Medical, speaker engagements for Abbott Laboratories, equity from Claret Medical and Elixir Medical, and Data Safety Monitoring Board fees to the institution from Atermark Research Partners. Dr Angiolillo reports payments, consulting fees, or honoraria from Amgen, Aralez, AstraZeneca, Bayer, Biosensors, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesi, Daiichi-Sankyo, Eli Lilly, Haemonetics, Janssen, Merck, PLx Pharma Inc, Pfizer, Sanofi, and The Medicines Company, fees for participation in review activities from CeloNova and St. Jude Medical, institutional grants from Amgen, AstraZeneca, Bayer, Biosensors, CeloNova, CSL Behring, Daiichi-Sankyo, Eisai, Eli Lilly, Gilead, Janssen, Matsutani Chemical Industry Co, Merck, Novartis, Osprey Medical, and Renal Guard Solutions, and funding from the Scott R. MacKenzie Foundation and the National Institutes of Health/National Center for Advancing Translational Sciences Clinical and Translational Science Award to the University of Florida UL1 TR000064 and National Institutes of Health/National Human Genome Research Institute U01 HG007269. Dr Byrne reports lecture fees from B. Braun Melsungen AG, Biotronik, Boston Scientific, and Micell Technologies and research funding to the institution from Boston Scientific and Celonova Biosciences. Dr Capodanno reports personal fees from Abbott Vascular, Bayer, Daiichi Sankyo, Pfizer, and AstraZeneca. Dr Cutlip reports receiving consultant fees from Celonova Biosciences and academic salary support from the Baim Institute for Clinical Research, an academic research organization in Boston, MA. Dr Eikelboom reports consulting fees and grant support from AstraZeneca, Bayer, Boehringer-Ingelheim, Bristol-Myers Squibb, Daiichi-Sankyo, Eli Lilly, GlaxoSmithKline, Pfizer, Janssen, and Sanofi-Aventis. Dr Gibson reports being chief executive officer of the Baim Institute for Clinical Research, in addition to receiving research grant funding from Angel Medical Corp, Bayer Corp, CSL Behring, Janssen Pharmaceuticals, Johnson & Johnson Corp, and Portola Pharmaceuticals, consultant fees from Amarin Pharama, Amgen, Bayer Corp, Boehringer Ingelheim, Boston Clinical Research Institute, Boston Scientific, Cardiovascular Research Foundation, CSL Behring, Chiesi, Duke Clinical Research Institute, Eli Lilly and Company, Gilead Sciences, Inc, Impact Bio LTD, Janssen Pharmaceuticals, Johnson & Johnson Corp, The Medicines Company, MedImmune, Medtelligence, Merck & Co, Inc, Microport, Novo Nordisk, PERT Consortium, Pharma Mar, Portola Pharmaceuticals, Sanofi, Somahlution, Vereseon Corporation, and Web MD, and royalties as a contributor from UpToDate in Cardiovascular Medicine. Dr Gregson reports personal fees from Edwards Lifesciences, MvRX, Amarin Corp, and BioSensors. Dr Haude reports grant support from Biotronik, Orbus Neich, AbboF, Medtronic, and Cardiac Dimensions, speaker’s bureau fees from Biotronik, Orbus Neich, AbboF, Medtronic, Lilly, Philips/ Volcano, and Cardiac Dimensions (Proctor), and consultant fees from Biotronik, Orbus Neich, and AbboF. Dr James reports institutional research grants from AstraZeneca, Bayer, Jansen, The Medicines Company, Abbot Vascular, and Boston Scientific, as well as honoraria from AstraZeneca, Bayer, and Medtronic. Dr Kimura reports consulting fees or honoraria from Abbott Vascular Japan Co, Ltd, Kowa Co, Ltd, Kowa Pharmaceutical Co Ltd, Sanofi K.K., Nippon Boehringer Ingelheim Co, Ltd, and Bristol-Myers Squibb K.K., as well as grant support from Otsuka Pharmaceutical Co, Ltd, Daiichi Sankyo Co, Ltd, Mitsubishi Tanabe Pharma Corp, Takeda Pharmaceutical Co Ltd, and Nippon Boehringer Ingelheim Co, Ltd. Dr Leon reports receiving research grants from Abbott Vascular, Boston Scientific, Medtronic, Biosensors, and SinomedEquity-Medinol. Dr Mylotte reports speaker fees from Biosensors and institutional research grants from Biosensors and Medtronic. Dr Pocock has served on steering committees or data monitoring committees for trials sponsored by AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Idorsia, Janssen, Medtronic, Novartis, Novo Nordisk, and Vifor, and has received grant funding from AstraZeneca and Merck. Dr Price reports receiving consulting honoraria from AstraZeneca, Chiesi USA, Medtronic, Boston Scientific, and Abbott Vascular/St Jude Medical, speaker’s bureau/fees from AstraZeneca, Chiesi USA, Medtronic, Boston Scientific, Abbott Vascular/St Jude Medical, and ACIST Medical, and institutional research grants from Daiichi-Sankyo. Dr Valgimigli reports grants and personal fees from Abbott, AstraZeneca, and Terumo, personal fees from Chiesi, Bayer, Daiichi Sankyo, Amgen, Alvimedica, Biosensors, and Idorsia, and grants from Medicure. Dr Varenne reports receiving consulting and research grants from Boston Scientific, Abbott Vascular, AstraZeneca, and Servier. Dr Yeh reports consulting and research grants from Abbott Vascular and Boston Scientific, research grants from Abiomed and AstraZeneca, and consulting fees from Biosense Webster, Medtronic, and Teleflex. Dr Krucoff reports receiving consulting and research grants from Abbott Vascular, Biosensors, Boston Scientific, Cook Medical, Medtronic, and OrbusNeich. Dr Morice is the chief executive officer of the Cardiovascular European Research Center, the contract research organization organizing the ARC-HBR initiative. The other authors report no conflicts., Kyoto University [Kyoto], Cardiology, Prémilleux, Annick
المصدر: Urban, Philip; Mehran, Roxana; Colleran, Roisin; Angiolillo, Dominick J; Byrne, Robert A; Capodanno, Davide; Cuisset, Thomas; Cutlip, Donald; Eerdmans, Pedro; Eikelboom, John; Farb, Andrew; Gibson, C Michael; Gregson, John; Haude, Michael; James, Stefan K; Kim, Hyo-Soo; Kimura, Takeshi; Konishi, Akihide; Laschinger, John; Leon, Martin B; ... (2019). Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk. European heart journal, 40(31), pp. 2632-2653. Oxford University Press 10.1093/eurheartj/ehz372 <http://dx.doi.org/10.1093/eurheartj/ehz372>
European Heart Journal
European Heart Journal, 2019, 40 (31), pp.2632-2653. ⟨10.1093/eurheartj/ehz372⟩
Urban, Philip; Mehran, Roxana; Colleran, Roisin; Angiolillo, Dominick J; Byrne, Robert A; Capodanno, Davide; Cuisset, Thomas; Cutlip, Donald; Eerdmans, Pedro; Eikelboom, John; Farb, Andrew; Gibson, C Michael; Gregson, John; Haude, Michael; James, Stefan K; Kim, Hyo-Soo; Kimura, Takeshi; Konishi, Akihide; Laschinger, John; Leon, Martin B; ... (2019). Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention: A Consensus Document From the Academic Research Consortium for High Bleeding Risk. Circulation, 140(3), pp. 240-261. Lippincott Williams & Wilkins 10.1161/CIRCULATIONAHA.119.040167 <http://dx.doi.org/10.1161/CIRCULATIONAHA.119.040167>
European Heart Journal, Oxford University Press (OUP): Policy B, 2019, 40 (31), pp.2632-2653. ⟨10.1093/eurheartj/ehz372⟩
European Heart Journal, 40(31), 2632-2653. Oxford University Press
Circulation 3 (140), 240-261. (2019)مصطلحات موضوعية: Percutaneous, protocole de recherche, medicine.medical_treatment, [SDV]Life Sciences [q-bio], Cardiologie et système cardiovasculaire, 030204 cardiovascular system & hematology, 0302 clinical medicine, maladie coronaire, Cardiac and Cardiovascular Systems, 030212 general & internal medicine, Aged, 80 and over, education.field_of_study, Clinical Trials as Topic, Kardiologi, Frailty, hémorragie, European research, Dual Anti-Platelet Therapy, Anemia, Drug-Eluting Stents, 3. Good health, ddc, Europe, [SDV] Life Sciences [q-bio], Treatment Outcome, Current Opinion, Metals, Stents, clinical trial protocols as topic, Safety, hemorrhage, Cardiology and Cardiovascular Medicine, medicine.medical_specialty, Asia, Consensus, Population, Clinical Decision-Making, 610 Medicine & health, Risk Assessment, Medication Adherence, Food and drug administration, 03 medical and health sciences, Physiology (medical), Hypertension, Portal, medicine, Humans, In patient, Acute Coronary Syndrome, Renal Insufficiency, Chronic, Intensive care medicine, education, Aged, business.industry, percutaneous coronary intervention, Percutaneous coronary intervention, Data interpretation, Fibrosis, Thrombocytopenia, United States, Clinical trial, Cardiology and cardiovascular system, business
وصف الملف: application/pdf
-
5
المؤلفون: Patrick W. Serruys, Hae Young Sohn, Gerrit-Anne van Es, William Wijns, Roberto Corti, Diethmar Antoni, Marie-Claude Morice, Axel Linke, Paweł Buszman, Samuel Copt, Carlo Di Mario, Yao-Jun Zhang, Pedro Eerdmans, Peter Jüni, Javaid Iqbal, Rana Saitta, Stephan Windecker
المساهمون: Cardiology
المصدر: Heart, 101(4), 271-278. BMJ Publishing Group
مصطلحات موضوعية: Male, medicine.medical_specialty, Time Factors, Polymers, medicine.medical_treatment, Myocardial Infarction, Kaplan-Meier Estimate, Coronary Angiography, Prosthesis Design, Risk Assessment, Coronary artery disease, Percutaneous Coronary Intervention, Coronary thrombosis, Predictive Value of Tests, Recurrence, Risk Factors, Internal medicine, Absorbable Implants, medicine, Odds Ratio, Humans, Myocardial infarction, cardiovascular diseases, Aged, Sirolimus, Interventional cardiology, business.industry, Coronary Thrombosis, Stent, Percutaneous coronary intervention, Cardiovascular Agents, Drug-Eluting Stents, Middle Aged, medicine.disease, Treatment Outcome, Cardiovascular agent, Cardiology, Female, Cardiology and Cardiovascular Medicine, business, Mace
-
6
المؤلفون: Paweł Buszman, Joanna J. Wykrzykowska, William Wijns, Pedro Eerdmans, Roberto Corti, Carlo Di Mario, Ton de Vries, Rodrigo Estévez-Loureiro, Hae Young Sohn, Gerrit-Anne van Es, Marie-Claude Morice, Axel Linke, Patrick W. Serruys, Matteo Ghione, Robert-Jan van Geuns, Stéphanie Konik, Diethmar Antoni, Peter Jüni, Stephan Windecker
المساهمون: Cardiology, ACS - Heart failure & arrhythmias
المصدر: Cardiology journal, 23(6), 626-636. Via Medica
Ghione, Matteo; Wykrzykowska, Joanna J; Windecker, Stephan; Serruys, Patrick W; Buszman, Pawel; Linke, Axel; Sohn, Hae Young; Corti, Roberto; Antoni, Diethmar; Wijns, William; Estevez-Loureiro, Rodrigo; Morice, Marie-Claude; Van Es, Gerrit-Anne; van Geuns, Robert Jan; Juni, Peter; Eerdmans, Pedro; De Vries, Ton; Konik, Stéphanie; Di Mario, Carlo (2016). Five-year outcomes of chronic total occlusion treatment with a biolimus A9-eluting biodegradable polymer stent versus a sirolimus-eluting permanent polymer stent in the LEADERS all-comers trial. Cardiology journal, 23(6), pp. 626-636. Via Medica 10.5603/CJ.a2016.0071 <http://dx.doi.org/10.5603/CJ.a2016.0071>
Cardiology Journal, 23(6), 626-636. Via Medicaمصطلحات موضوعية: Male, medicine.medical_specialty, Polymers, medicine.medical_treatment, Target vessel revascularization, 610 Medicine & health, 030204 cardiovascular system & hematology, Coronary Angiography, Prosthesis Design, Total occlusion, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Absorbable Implants, medicine, Clinical endpoint, Humans, 030212 general & internal medicine, Myocardial infarction, Prospective Studies, Sirolimus, business.industry, Incidence (epidemiology), Stent, Drug-Eluting Stents, General Medicine, Middle Aged, medicine.disease, Surgery, Treatment Outcome, Coronary Occlusion, Chronic Disease, Cardiology, Female, Cardiology and Cardiovascular Medicine, business, Mace, Immunosuppressive Agents, medicine.drug, Follow-Up Studies
وصف الملف: application/pdf
-
7
المؤلفون: Philip, Urban, Mariano, Valdés, Ian, Menown, Franz, Eberli, Imad, Alhaddad, David, Hildick-Smith, David, Iosseliani, Marco, Roffi, Keith, Oldroyd, Erifyli, Kalloudi, Pedro, Eerdmans, Jacques, Berland, Franz Xaver, Kleber, Susanne, Meis
المصدر: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventions. 86(7)
مصطلحات موضوعية: Male, Sirolimus, Time Factors, Coronary Thrombosis, Incidence, Myocardial Infarction, Cardiovascular Agents, Drug-Eluting Stents, Comorbidity, Coronary Artery Disease, Kaplan-Meier Estimate, Middle Aged, Percutaneous Coronary Intervention, Treatment Outcome, Risk Factors, Humans, Drug Therapy, Combination, Female, Registries, Platelet Aggregation Inhibitors, Aged, Proportional Hazards Models
-
8
المؤلفون: Bernhard Meier, Ton de Vries, Joanna J. Wykrzykowska, Pedro Eerdmans, Peter Jüni, Carlo Di Mario, Stanislaw Trznadel, Karsten Lenk, Robert-Jan van Geuns, Paweł Buszman, Stephan Windecker, Paweł Tyczyński, Gerrit-Anne van Es, Volker Klauss, Franz R. Eberli, Thomas Ischinger, Roberto Corti, Scot Garg, Marie-Claude Morice, Axel Linke, Patrick W. Serruys, William Wijns
المساهمون: Cardiology, Radiology & Nuclear Medicine, University of Zurich
المصدر: EuroIntervention, 6(8), 928-935. EuroPCR
Garg, Scot; Wykrzykowska, Joanna; Serruys, Patrick W; de Vries, Ton; Buszman, Pawel; Trznadel, Stanislaw; Linke, Axel; Lenk, Karsten; Ischinger, Thomas; Klauss, Volker; Eberli, Franz; Corti, Roberto; Wijns, William; Morice, Marie-Claude; di Mario, Carlo; Tyczynski, Pawel; van Geuns, Robert Jan; Eerdmans, Pedro; van Es, Gerrit-Anne; Meier, Bernhard; ... (2011). The outcome of bifurcation lesion stenting using a biolimus-eluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer. EuroIntervention, 6(8), pp. 928-935. Toulouse: Europa Digital & Publishingمصطلحات موضوعية: Male, medicine.medical_specialty, Polymers, medicine.medical_treatment, Myocardial Infarction, 610 Medicine & health, Coronary Artery Disease, Kaplan-Meier Estimate, 2705 Cardiology and Cardiovascular Medicine, Internal medicine, Durable polymer, Absorbable Implants, Clinical endpoint, Medicine, Humans, Myocardial infarction, cardiovascular diseases, Acute Coronary Syndrome, Angioplasty, Balloon, Coronary, Aged, Sirolimus, Protein synthesis inhibitor, business.industry, Stent, Drug-Eluting Stents, Middle Aged, medicine.disease, equipment and supplies, Surgery, surgical procedures, operative, Treatment Outcome, Drug-eluting stent, Cardiology, 10209 Clinic for Cardiology, Female, Cardiology and Cardiovascular Medicine, business, Mace, medicine.drug, Follow-Up Studies
وصف الملف: application/pdf
-
9
المؤلفون: Thomas Ischinger, Roberto Corti, Giulio G. Stefanini, Franz R. Eberli, Carlo Di Mario, Marie-Claude Morice, Axel Linke, Bindu Kalesan, Bernhard Meier, Diethmar Antoni, Volker Klauss, Peter Jüni, Dik Heg, Hae Y. Sohn, Paweł Buszman, Pedro Eerdmans, Gerrit-Anne van Es, Patrick W. Serruys, William Wijns, Stephan Windecker
المساهمون: Cardiology, University of Zurich, Windecker, S
المصدر: Lancet (UK), 378(9807), 1940-1948. Elsevier Ltd.
مصطلحات موضوعية: medicine.medical_specialty, Polymers, 610 Medicine & health, 2700 General Medicine, Coronary Artery Disease, law.invention, Coronary artery disease, Randomized controlled trial, law, Absorbable Implants, medicine, Clinical endpoint, Humans, Myocardial infarction, Adverse effect, Sirolimus, Intention-to-treat analysis, business.industry, Drug-Eluting Stents, Thrombosis, General Medicine, medicine.disease, Biodegradable polymer, Surgery, 10209 Clinic for Cardiology, business, medicine.drug, Follow-Up Studies
-
10
المؤلفون: Pedro Eerdmans, Giovanna Sarno, Ton de Vries, Volker Klauss, Carlo Di Mario, Gerrit-Anne van Es, Yoshinobu Onuma, William Wijns, Peter Jüni, Paweł Buszman, Dick Goedhart, Bernhard Meier, Franz R. Eberli, Patrick W. Serruys, Stephan Windecker, Thomas Ischinger, Roberto Corti, Scot Garg, Marie-Claude Morice, Axel Linke, Hector M. Garcia-Garcia
المصدر: Journal of the American College of Cardiology. 55(10)
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Sirolimus, Conventional PCI, medicine, business, Cardiology and Cardiovascular Medicine, Body mass index, Outcome (game theory), medicine.drug, Surgery
-
11
المؤلفون: Carlo Di Mario, Giuseppe Ferrante, Stephan Windecker, Konstantinos Dimopoulos, Pedro Eerdmans, Peter Barlis, Peter Jüni, Patrick W. Serruys, Robert-Jan van Geuns, Evelyn Regar, Simon Wandel, Willem J. van der Giessen, Gerrit Anne van Es
المساهمون: Cardiology, Radiology & Nuclear Medicine
المصدر: Barlis, Peter; Regar, Evelyn; Serruys, Patrick W; Dimopoulos, Konstantinos; van der Giessen, Willem J; van Geuns, Robert-Jan M; Ferrante, Giuseppe; Wandel, Simon; Windecker, Stephan; van Es, Gerrit-Anne; Eerdmans, Pedro; Jüni, Peter; di Mario, Carlo (2010). An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study. European Heart Journal, 31(2), pp. 165-176. Oxford: Oxford University Press 10.1093/eurheartj/ehp480 <http://dx.doi.org/10.1093/eurheartj/ehp480>
European Heart Journal, 31(2), 165-176. Oxford University Pressمصطلحات موضوعية: Male, medicine.medical_specialty, Polymers, medicine.medical_treatment, 610 Medicine & health, law.invention, Lesion, Coronary Restenosis, chemistry.chemical_compound, Randomized controlled trial, law, 360 Social problems & social services, Umirolimus, Intravascular ultrasound, Absorbable Implants, Medicine, Humans, cardiovascular diseases, Sirolimus, medicine.diagnostic_test, business.industry, Graft Occlusion, Vascular, Stent, Drug-Eluting Stents, Middle Aged, medicine.disease, equipment and supplies, Thrombosis, Confidence interval, Tubulin Modulators, Treatment Outcome, surgical procedures, operative, chemistry, Drug-eluting stent, Female, Radiology, medicine.symptom, Cardiology and Cardiovascular Medicine, business, Tomography, Optical Coherence
وصف الملف: application/pdf
-
12
المؤلفون: Robert-Jan van Geuns, Thomas Ischinger, Roberto Corti, Patrick W. Serruys, Pedro Eerdmans, William Wijns, Carlo Di Mario, Scot Garg, Marie-Claude Morice, Giovanna Sarno, Axel Linke, Dick Goedhart, Volker Klauss, Gerrit-Anne van Es, Peter Jüni, Ton de Vries, Paweł Buszman, Bernhard Meier, Stephan Windecker, Yoshinobu Onuma, Franz R. Eberli, Hector M. Garcia-Garcia
المساهمون: Cardiology, Radiology & Nuclear Medicine
المصدر: American Journal of Cardiology, 105(4), 475-479. Elsevier Inc.
مصطلحات موضوعية: Male, medicine.medical_specialty, medicine.medical_treatment, Myocardial Infarction, Body Mass Index, Atherectomy, Predictive Value of Tests, Risk Factors, Angioplasty, Internal medicine, Confidence Intervals, Odds Ratio, medicine, Humans, Obesity, cardiovascular diseases, Myocardial infarction, Angioplasty, Balloon, Coronary, Aged, Netherlands, Proportional Hazards Models, Sirolimus, business.industry, Hazard ratio, Stent, Percutaneous coronary intervention, Drug-Eluting Stents, Middle Aged, Overweight, Clopidogrel, medicine.disease, Survival Analysis, Surgery, Treatment Outcome, Drug-eluting stent, Cardiology, Female, Cardiology and Cardiovascular Medicine, business, Immunosuppressive Agents, Follow-Up Studies, medicine.drug
-
13
المؤلفون: Paweł Buszman, Stephan Windecker, Thomas Ischinger, Carlo Di Mario, Roberto Corti, Ton de Vries, William Wijns, Gerrit Anne van Es, Volker Klauss, Scot Garg, Marie-Claude Morice, Axel Linke, Giovanna Sarno, Patrick W. Serruys, Peter Jüni, Franz R. Eberli, B. Meier, Pedro Eerdmans, Robert-Jan van Geuns
المساهمون: Cardiology, University of Zurich
المصدر: EuroIntervention, 6(2), 233-239. EuroPCR
Garg, Scot; Sarno, Giovanna; Serruys, Patrick W; de Vries, Ton; Buszman, Pawel; Linke, Axel; Ischinger, Thomas; Klauss, Volker; Eberli, Franz; Corti, Roberto; Wijns, William; Morice, Marie-Claude; Di Mario, Carlo; van Geuns, Robert Jan; Eerdmans, Pedro; van Es, Gerrit-Anne; Meier, Bernhard; Jüni, Peter; Windecker, Stephan (2010). The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer. EuroIntervention, 6(2), pp. 233-239. Toulouse: Europa Digital & Publishingمصطلحات موضوعية: Male, medicine.medical_specialty, Time Factors, Polymers, medicine.medical_treatment, Polyesters, Treatment outcome, 610 Medicine & health, 2705 Cardiology and Cardiovascular Medicine, Durable polymer, Absorbable Implants, medicine, Humans, cardiovascular diseases, Lactic Acid, Prospective Studies, Sirolimus, business.industry, Biolimus eluting stent, Follow up studies, Stent, Drug-Eluting Stents, Middle Aged, equipment and supplies, Biodegradable polymer, Surgery, surgical procedures, operative, Treatment Outcome, Drug-eluting stent, 10209 Clinic for Cardiology, Female, Cardiology and Cardiovascular Medicine, business, medicine.drug, Follow-Up Studies
وصف الملف: LEADERS_12_months.pdf - application/pdf; LEADERS_12_months_epub_2010.pdf - application/pdf; application/pdf
-
14
المؤلفون: Gerrit Anne van Es, Simon J. Davies, Stanislaw Trznadel, Simon Wandel, Thomas Ischinger, Roberto Corti, Karsten Lenk, Robert-Jan van Geuns, Marie-Claude Morice, Carlo Di Mario, Axel Linke, Stephan Windecker, Volker Klauss, Pedro Eerdmans, B. Meier, William Wijns, Paweł Buszman, Patrick W. Serruys, Franz R. Eberli, Peter Jüni
المساهمون: Cardiology, Radiology & Nuclear Medicine, University of Zurich, Windecker, S
المصدر: Lancet (UK), 372(9644), 1163-1173. Elsevier Ltd.
مصطلحات موضوعية: Male, medicine.medical_specialty, Polymers, medicine.medical_treatment, 610 Medicine & health, Biocompatible Materials, Coronary Disease, 2700 General Medicine, Revascularization, Coronary artery disease, Internal medicine, Absorbable Implants, Materials Testing, medicine, Clinical endpoint, Humans, Myocardial infarction, cardiovascular diseases, Antibacterial agent, Aged, Sirolimus, Intention-to-treat analysis, business.industry, Stent, Drug-Eluting Stents, Thrombosis, General Medicine, Middle Aged, medicine.disease, equipment and supplies, Surgery, surgical procedures, operative, Treatment Outcome, Drug-eluting stent, Metals, Chronic Disease, 10209 Clinic for Cardiology, Cardiology, Female, business
-
15
المؤلفون: Pedro Eerdmans, Samantha Greene, Ian T. Meredith, Philip Urban, Alexandre Abizaid, Marie-Claude Morice
المصدر: Journal of the American College of Cardiology. 64:B144
مصطلحات موضوعية: medicine.medical_specialty, education.field_of_study, animal structures, business.industry, Population, medicine, Physical therapy, Alternative medicine, Free trial, Cardiology and Cardiovascular Medicine, Intensive care medicine, business, education